Japanese CRISPR Patent and Biotech Developments in the Early Reiwa Era

IF 0.2 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology Law Report Pub Date : 2021-05-13 DOI:10.1089/BLR.2021.29234.JAT

J. A. Tessensohn

引用次数: 0

Abstract

On February 25, 2020, in the second year of the Reiwa era, the Intellectual Property High Court of Japan (IPHCJ) issued two appellate decisions relating to the groundbreaking, Nobel Prize–winning, ...

查看原文本刊更多论文

日本CRISPR专利与Reiwa时代早期的生物技术发展

2020年2月25日，在令和时代的第二年，日本知识产权高等法院(IPHCJ)发布了两项与诺贝尔奖获奖的开创性，…

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biotechnology Law Report 工程技术-生物工程与应用微生物

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.